Covered recipient · General Payments record
RYAN H JOO
Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease
General Payments · PY2018–2024
$1,567.27
- Reported across 47 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $515.13 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $273.62 | 6 |
| Gilead Sciences, Inc. | $184.80 | 9 |
| Merck Sharp & Dohme Corporation | $31.72 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $24.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.49 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010754 | CMS |
| ABBVIE INC. | $12.26 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010756 | CMS |
| ABBVIE INC. | $125.00 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010758 | CMS |
| ABBVIE INC. | $15.75 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010760 | CMS |
| ABBVIE INC. | $77.05 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010762 | CMS |
| ABBVIE INC. | $29.07 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104010764 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $24.99 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146976592 | CMS |
| Gilead Sciences, Inc. | $8.08 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133824374 | CMS |
| Gilead Sciences, Inc. | $4.66 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133824376 | CMS |
| Gilead Sciences, Inc. | $7.50 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133824378 | CMS |
| Gilead Sciences, Inc. | $8.56 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133824380 | CMS |
| Gilead Sciences, Inc. | $124.65 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133824382 | CMS |
| Gilead Sciences, Inc. | $7.55 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133824384 | CMS |
| Gilead Sciences, Inc. | $4.86 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133824386 | CMS |
| Gilead Sciences, Inc. | $7.83 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133824388 | CMS |
| Gilead Sciences, Inc. | $11.11 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133824390 | CMS |
| Merck Sharp & Dohme LLC | $31.72 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141852793 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.